Frontlight ResearchEarly access
Childhood cancers trials in Italy
205 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in ItalyRoll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.
- Where
- Milan, Padova
- People
- 51 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07679269 · EU 2026-525890-38-00 - Phase 1/2Taking peopleA Phase 1/2 study of Enzomenib (DSP-5336) in Patients with Acute leukemia
- Where
- Bologna, Busto Arsizio, Genoa, Meldola, Padova, Perugia, Ravenna, Rome, Turin
- People
- 94 worldwide
- Run by
- Sumitomo Pharma America Inc.
See details and how to join2022-502741-10-00 - No phaseNot yet taking people in ItalyEffectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour
- Where
- Milan, Padova
- Age
- 10 years to 40 years
- People
- 120 worldwide
- Run by
- Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT07558395 - Phase 3Taking peopleAn international trial for children with atypical teratoid/rhabdoid tumours (ATRT)
- Where
- Bologna, Milan, Naples, Padova, Rome, Turin
- Age
- Up to 17 years
- People
- 301 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501456-28-00 - No phaseTaking peopleTo Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer
- Where
- Prato
- People
- 150
- Run by
- Fondazione Sandro Pitigliani
See details and how to joinNCT04660435 - Phase 3Taking peopleStudy to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Where
- Ferrara, Genoa, Milan, Negrar, Pisa, Rome, Rozzano
- Age
- 12 years to 100 years
- People
- 240 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00 - No phaseTaking peopleDisparities in Mental Health Screening and Support
- Where
- Milan
- People
- 2,000
- Run by
- European Institute of Oncology
See details and how to joinNCT07691281 - Phase 1Taking peoplePhase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Where
- Candiolo, Milan
- Age
- 12 years to 85 years
- People
- 411 worldwide
- Run by
- Inhibrx Biosciences, Inc
See details and how to joinNCT03715933 · EU 2023-508139-29-00 - Phase 3Not yet taking people in ItalySIOP RANDOMET 2017
- Where
- Bari, Catania, Milan, Padova, Rome, Turin
- Age
- Up to 17 years
- People
- 409 worldwide
- Run by
- GPOH gGmbH
See details and how to join2023-508926-91-00 - Phase 3Taking peopleSIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years.
- Where
- Ancona, Bari, Bologna, Cagliari, Catania, Genoa, Milan, Naples, Padova, Rome, Turin, Udine, Verona
- Age
- Up to 64 years
- People
- 311 worldwide
- Run by
- The University Of Birmingham
See details and how to join2024-510578-25-00 - Phase 2/3Active, not recruitingAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Monza, Pavia, Rome
- Age
- 1 month to 18 years
- People
- 1,800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - No phaseTaking peopleAdjuvant Treatment in Premenopausal Breast Cancer
- Where
- Roma, Salerno
- Age
- Up to 60 years
- People
- 800
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06807749 - Early phase 1Taking peopleNovel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma
- Where
- Roma
- Age
- 0 years to 18 years
- People
- 60
- Run by
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06959979 - Phase 2Taking peopleStudy to evaluate the safety and efficacy of asciminib in pediatric participants with chronic myeloid leukemia.
- Where
- Padova, Rome
- Age
- Up to 17 years
- People
- 16 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-522138-29-00 - No phaseTaking peopleSurgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer
- Where
- Milan
- People
- 50
- Run by
- European Institute of Oncology
See details and how to joinNCT07790406 - No phaseTaking peopleStudy on Plasmablastic Lymphoma Patients
- Where
- Ascoli Piceno, Aviano, Brescia, Cuneo, Florence, Milan, Monza, Novara, Padova, Pagani, Reggio Emilia, Roma, Siena, Torino, Trento, Treviso, Vicenza
- Age
- 15 years and over
- People
- 200
- Run by
- Fondazione Italiana Linfomi - ETS
See details and how to joinNCT06781359 - No phaseTaking peopleIbrutinib Plus Venetoclax Long-Term Outcomes in CLL
- Where
- Milan
- People
- 323
- Run by
- European Research Initiative on CLL
See details and how to joinNCT07774390 - Phase 1Taking peopleLong-Term Follow-Up (LTFU) of Participants Treated with Adoptive Cell Therapies
- Where
- Milan
- People
- 7 worldwide
- Run by
- USWM Ct LLC
See details and how to join2024-513033-21-00 - No phaseTaking peopleCerebellar Mutism Syndrome Study
- Where
- Rome
- Age
- Up to 18 years
- People
- 2,000 worldwide
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT02300766 - No phaseNot yet taking people in ItalyVirtual Reality in Lung Cancer Patients
- Where
- Olbia
- Age
- 18 months to 80 years
- People
- 60
- Run by
- Dott.Claudio Sini
See details and how to joinNCT07755501 - Phase 1Enrolling by invitationAdoptive Cell Therapy Long-term Follow-up (LTFU) Study
- Where
- Milan
- People
- 250 worldwide
- Run by
- USWM CT, LLC
See details and how to joinNCT03391778 - Phase 2Taking peopleA Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Where
- Bologna, Candiolo, Milan, Padova, Roma, Rozzano
- Age
- 1 year to 39 years
- People
- 105 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05999994 - Phase 2Not yet taking people in ItalyRevumenib Treatment in Combination with FLA Chemotherapy in Paediatric Refractory/Relapsed KMT2A-r, NUP98-r or NPM1-mut Acute Myeloid Leukemia (AML)
- Where
- Bologna, Monza, Naples, Padova, Rome
- Age
- Up to 64 years
- People
- 31 worldwide
- Run by
- Pediatric Research International GmbH
See details and how to join2025-521390-14-00 - Phase 1/2Not yet taking people in ItalyStudy testing a new experimental cell therapy in adults and children With Relapsed or Refractory Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm
- Where
- Bergamo, Monza
- People
- 18
- Run by
- Fondazione Tettamanti
See details and how to join2025-524977-18-00 - Phase 2Taking peopleA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Where
- Meldola, Milan, Naples
- Age
- 8 years and over
- People
- 254 worldwide
- Run by
- Fore Biotherapeutics
See details and how to joinNCT05503797 · EU 2024-513578-23-00